243 related articles for article (PubMed ID: 29759689)
21. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
[TBL] [Abstract][Full Text] [Related]
22. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results.
Auricchio A; Schloss EJ; Kurita T; Meijer A; Gerritse B; Zweibel S; AlSmadi FM; Leng CT; Sterns LD;
Heart Rhythm; 2015 May; 12(5):926-36. PubMed ID: 25637563
[TBL] [Abstract][Full Text] [Related]
23. Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis.
Al-Khatib SM; Fonarow GC; Joglar JA; Inoue LYT; Mark DB; Lee KL; Kadish A; Bardy G; Sanders GD
JAMA Cardiol; 2017 Jun; 2(6):685-688. PubMed ID: 28355432
[TBL] [Abstract][Full Text] [Related]
24. Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry.
Bogossian H; Frommeyer G; Hochadel M; Ince H; Spitzer SG; Eckardt L; Maier SKG; Kleemann T; Brachmann J; Stellbrink C; Gonska BD; Kääb S; Senges J; Lemke B
Clin Res Cardiol; 2020 Jul; 109(7):911-917. PubMed ID: 31823040
[TBL] [Abstract][Full Text] [Related]
25. Clinical predictors of atrial defibrillation thresholds with a dual-coil, active pectoral lead system.
Rashba EJ; Shorofsky SR; Brown T; Peters RW; Gold MR
Heart Rhythm; 2005 Jan; 2(1):49-54. PubMed ID: 15851265
[TBL] [Abstract][Full Text] [Related]
26. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
Stavrakis S; Asad Z; Reynolds D
J Cardiovasc Electrophysiol; 2017 Jun; 28(6):659-665. PubMed ID: 28316104
[TBL] [Abstract][Full Text] [Related]
27. Determinants of Subcutaneous Implantable Cardioverter-Defibrillator Efficacy: A Computer Modeling Study.
Heist EK; Belalcazar A; Stahl W; Brouwer TF; Knops RE
JACC Clin Electrophysiol; 2017 Apr; 3(4):405-414. PubMed ID: 29759454
[TBL] [Abstract][Full Text] [Related]
28. Efficiencies and Complications of Dual Chamber versus Single Chamber Implantable Cardioverter Defibrillators in Secondary Sudden Cardiac Death Prevention: A Meta-analysis.
Hu ZY; Zhang J; Xu ZT; Gao XF; Zhang H; Pan C; Chen SL
Heart Lung Circ; 2016 Feb; 25(2):148-54. PubMed ID: 26338316
[TBL] [Abstract][Full Text] [Related]
29. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.
Basu-Ray I; Liu J; Jia X; Gold M; Ellenbogen K; DiNicolantonio J; Komócsi A; Vorobcsuk A; Kim J; Afshar H; Lam W; Mathuria N; Razavi M; Rasekh A; Saeed M
JACC Clin Electrophysiol; 2017 Dec; 3(13):1475-1483. PubMed ID: 29759827
[TBL] [Abstract][Full Text] [Related]
30. Implantable Cardioverter Defibrillator Implantation with or Without Defibrillation Testing.
Duffett S; El Hajjaji I; Manlucu J; Yee R
Card Electrophysiol Clin; 2018 Mar; 10(1):119-125. PubMed ID: 29428133
[TBL] [Abstract][Full Text] [Related]
31. Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis.
Akel T; Lafferty J
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28129469
[TBL] [Abstract][Full Text] [Related]
32. Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure.
Elming MB; Nielsen JC; Haarbo J; Videbæk L; Korup E; Signorovitch J; Olesen LL; Hildebrandt P; Steffensen FH; Bruun NE; Eiskjær H; Brandes A; Thøgersen AM; Gustafsson F; Egstrup K; Videbæk R; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Køber L; Thune JJ
Circulation; 2017 Nov; 136(19):1772-1780. PubMed ID: 28877914
[TBL] [Abstract][Full Text] [Related]
33. A prospective randomized trial of single- or dual-chamber implantable cardioverter-defibrillators to minimize inappropriate shock risk in primary sudden cardiac death prevention.
Friedman PA; Bradley D; Koestler C; Slusser J; Hodge D; Bailey K; Kusumoto F; Munger TM; Militanu A; Glikson M
Europace; 2014 Oct; 16(10):1460-8. PubMed ID: 24928948
[TBL] [Abstract][Full Text] [Related]
34. Characteristics and early clinical outcomes of patients undergoing totally subcutaneous vs. transvenous single chamber implantable cardioverter defibrillator placement.
Mithani AA; Kath H; Hunter K; Andriulli J; Ortman M; Field J; Russo AM
Europace; 2018 Feb; 20(2):308-314. PubMed ID: 28383717
[TBL] [Abstract][Full Text] [Related]
35. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
[TBL] [Abstract][Full Text] [Related]
36. Primary prevention implantation of cardioverter defibrillator without defibrillation threshold testing: 2-year follow-up.
Bianchi S; Ricci RP; Biscione F; Sgreccia F; Di Belardino N; Rossi P; Giuli S; Grammatico A; De Santo T; Santi E; Merico M; Piccirillo G; Azzolini P; Santini M; Puglisi A
Pacing Clin Electrophysiol; 2009 May; 32(5):573-8. PubMed ID: 19422577
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of non-transvenous cardioverter defibrillators in infants and young children.
Müller MJ; Dieks JK; Backhoff D; Schneider HE; Ruschewski W; Tirilomis T; Paul T; Krause U
J Interv Card Electrophysiol; 2019 Mar; 54(2):151-159. PubMed ID: 30255451
[TBL] [Abstract][Full Text] [Related]
38. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
[TBL] [Abstract][Full Text] [Related]
39. Use of implantable cardioverter-defibrillators for primary prevention in older patients: a systematic literature review and meta-analysis.
Kong MH; Al-Khatib SM; Sanders GD; Hasselblad V; Peterson ED
Cardiol J; 2011; 18(5):503-14. PubMed ID: 21947985
[TBL] [Abstract][Full Text] [Related]
40. Defibrillation thresholds with right pectoral implantable cardioverter defibrillators and impact of waveform tuning (the Tilt and Tune trial).
Varma N; Schaerf R; Kalbfleisch S; Pimentel R; Kroll MW; Oza A
Europace; 2017 Nov; 19(11):1810-1817. PubMed ID: 27986795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
